Cabozantinib in patients with unresectable and progressive metastatic phaeochromocytoma or paraganglioma (the Natalie Trial): a single-arm, phase 2 trial
Camilo Jiménez, Mouhammed Amir Habra, Matthew T. Campbell, Gina Tamsen, Damaris Cruz-Goldberg, James P. Long, Roland L. Bassett, Robert Dantzer, Vania Balderrama-Brondani, Jeena Varghese, Yang Lü
Topics & Concepts
CabozantinibMedicineClinical endpointInternal medicineAdverse effectClinical trialAsymptomaticResponse Evaluation Criteria in Solid TumorsParagangliomaOncologyCancerPhases of clinical researchSurgeryAdrenal and Paraganglionic TumorsPituitary Gland Disorders and TreatmentsCancer, Hypoxia, and Metabolism